• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA ACCEL PLT,PLASMA,ISBT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA ACCEL PLT,PLASMA,ISBT Back to Search Results
Model Number 80300
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Hemorrhage/Bleeding (1888); Hematuria (2558)
Event Date 04/10/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer performed a double platelet donation and the collection procedure was fluent and the donor's status was good during the run.On the next day of platelet donation, the patient developed bleeding gums and hematuria.Per the customer, pre-donation process showed nothing abnormal and the door qualified as available for donation.The donor went to hospital on (b)(6) 2023, the preliminary clinical diagnosis was "coagulant function abnormality".It is unknown at this time if medical intervention was required for this event.Patient id is not available at this time.The platelet collection set is not available for return because it was discarded by the customer.
 
Event Description
The customer performed a double platelet donation and the collection procedure was fluent and the donor's status was good during the run.On the next day of platelet donation, the patient developed bleeding gums and hematuria.Per the customer, pre-donation process showed nothing abnormal and the door qualified as available for donation.The donor went to hospital on (b)(6) 2023, the preliminary clinical diagnosis was "coagulant function abnormality".It is unknown at this time if medical intervention was required for this event.The customer declined to provide the patient identifier.The platelet collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: a disposable complaint history search was performed for this lot and found no reports for similar issues on this lot worldwide.According to aabb technical manual 20th edition, adverse reactions can occur at the time of donation or after the donor has left the blood center.In a comprehensive donor hemovigilance program reported by the american red cross, adverse reactions were reported for wb collections (349 in 10,000), plateletpheresis (578 in 10,000), and double rbc unit collections (538 in 10,000), the vast majority of which were minor presyncopal reactions and small hematomas.Serious adverse reactions were slightly more common for wb collections (7.4 in 10,000) compared with plateletpheresis (5.2 in 10,000) and double rbc unit collections (3.3 in 10,000).Reactions that needed medical care after the donor left the donation site occurred in roughly 3 in 10,000 donations.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer performed a double platelet donation and the collection procedure was fluent and the donor's status was good during the run.On the next day of platelet donation, the patient developed bleeding gums and hematuria.Per the customer, pre-donation process showed nothing abnormal and the door qualified as available for donation.The donor went to hospital on (b)(6) 2023, the preliminary clinical diagnosis was "coagulant function abnormality".It is unknown at this time if medical intervention was required for this event.The customer declined to provide the patient identifier.The platelet collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: a disposable complaint history search was performed for this lot and found no reports for similar issues on this lot worldwide.According to aabb technical manual 20th edition, adverse reactions can occur at the time of donation or after the donor has left the blood center.In a comprehensive donor hemovigilance program reported by the american red cross, adverse reactions were reported for wb collections (349 in 10,000), plateletpheresis (578 in 10,000), and double rbc unit collections (538 in 10,000), the vast majority of which were minor presyncopal reactions and small hematomas.Serious adverse reactions were slightly more common for wb collections (7.4 in 10,000) compared with plateletpheresis (5.2 in 10,000) and double rbc unit collections (3.3 in 10,000).Reactions that needed medical care after the donor left the donation site occurred in roughly 3 in 10,000 donations.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The run data file (rdf) was analyzed for this event.Run data file analysis confirmed the donor height and weight information was entered into trima as reported.Analysis showed one ¿draw pressure too low¿ alert was raised shortly after the donor was connected and the ¿start draw¿ button was pressed.There were no additional alerts raised throughout the procedure nor any operator adjustments made.The draw flow from the donor was automatically increased 6 times during the procedure due to good venous access during the collection.Analysis of the run data file confirmed the ac infusion rate and return flow rates remained below the configured maximum limits.The end of run summary reported the total ac used was 387ml, with 293ml of ac returned to the donor.There is no evidence or suspicion of device malfunction based on the run data file analysis.Root cause: a root cause assessment was performed for this complaint.A definitive root cause for the donor's reaction could not be determined.Possible causes for the alleged reaction include but are not limited to donor's physiology and/or donor's sensitivity to the procedure.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.5 and h.10.Investigation: a disposable complaint history search was performed for this lot and found no reports for similar issues on this lot worldwide.According to aabb technical manual 20th edition, adverse reactions can occur at the time of donation or after the donor has left the blood center.In a comprehensive donor hemovigilance program reported by the american red cross, adverse reactions were reported for wb collections (349 in 10,000), plateletpheresis (578 in 10,000), and double rbc unit collections (538 in 10,000), the vast majority of which were minor presyncopal reactions and small hematomas.Serious adverse reactions were slightly more common for wb collections (7.4 in 10,000) compared with plateletpheresis (5.2 in 10,000) and double rbc unit collections (3.3 in 10,000).Reactions that needed medical care after the donor left the donation site occurred in roughly 3 in 10,000 donations.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The run data file (rdf) was analyzed for this event.Run data file analysis confirmed the donor height and weight information was entered into trima as reported.Analysis showed one ¿draw pressure too low¿ alert was raised shortly after the donor was connected and the ¿start draw¿ button was pressed.There were no additional alerts raised throughout the procedure nor any operator adjustments made.The draw flow from the donor was automatically increased 6 times during the procedure due to good venous access during the collection.Analysis of the run data file confirmed the ac infusion rate and return flow rates remained below the configured maximum limits.The end of run summary reported the total ac used was 387ml, with 293ml of ac returned to the donor.There is no evidence or suspicion of device malfunction based on the run data file analysis.Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer performed a double platelet donation and the collection procedure was fluent and the donor's status was good during the run.On the next day of platelet donation, the patient developed bleeding gums and hematuria.Per the customer, pre-donation process showed nothing abnormal and the door qualified as available for donation.The donor went to hospital on (b)(6) 2023, the preliminary clinical diagnosis was "coagulant function abnormality".It is unknown at this time if medical intervention was required for this event.The customer declined to provide the patient identifier.The platelet collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA ACCEL PLT,PLASMA,ISBT
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key16913181
MDR Text Key315030225
Report Number1722028-2023-00179
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583803008
UDI-Public05020583803008
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
BK190332
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 05/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number80300
Device Catalogue Number5803002
Device Lot Number2209125251
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/19/2023
Initial Date FDA Received05/11/2023
Supplement Dates Manufacturer Received06/19/2023
06/30/2023
07/25/2023
Supplement Dates FDA Received06/27/2023
07/20/2023
07/25/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age38 YR
Patient SexMale
Patient Weight90 KG
-
-